Ataxin-2 is also implicated in diseases with phenotypes that are outside of the cerebellar spectrum, most prominently L-DOPA responsive Parkinsonism and ALS (Elden et al., 2010; Scoles and Pulst, 2018). This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.